World Health Organization (WHO). There is a rise of 10 million new cases every year. What’s more concerning is that this ...

Researchers identified over 400 genes tied to various forms of frailty, offering fresh insight into why people age differently. The study highlights six distinct pathways of unhealthy aging, opening ...

"A chain reaction." Scientists issue warning on overlooked factor that could exacerbate Alzheimer's: 'Spreads from the top ...

A new study suggests that music therapy could help improve care for people with dementia in NHS hospitals. The treatment, ...

Scientists at St. Jude Children's Research Hospital demonstrated for the first time that the protein midkine plays a ...

Headquartered in Chicago, the company’s mission is clear: to make early detection of Alzheimer’s and other neurodegenerative ...

The guidelines include eating a heart-healthy diet, exercising, abstaining from smoking, and maintaining body weight, blood glucose, cholesterol and blood pressure within healthy limits. (Getting good ...

Nantz said Pepper, “a treasured friend and teammate,” informed him of the Saratoga Senior Center’s work and asked him to visit. Nantz said he spends about 100 days per year on ...

Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.

New hypertension guidelines from the American Heart Association (AHA) reaffirm earlier recommendations and include some key ...

Scientists at UC San Francisco and Gladstone Institutes have discovered that two cancer drugs may help reverse changes in the brain caused by Alzheimer’s disease.

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.